Not applicable (submitted trial is a BE study in healthy participants) research hub

Bioequivalence Study of Empagliflozin

This study is looking at how two versions of a diabetes medicine called empagliflozin work in the body. It's a type of check to make sure they're absorbed in a similar way. Healthy adults can take part.